Diversified Tracked since Q2 FY26 - Q2 FY26

Dr. Reddy's Laboratories Limited

Compare with...

DRREDDY

Latest quarter Q2 FY26

Revenue ₹8,828 Cr (+10% YoY)

Management credibility Building

Promise tracking available after 2+ quarters of coverage.

Latest signal neutral medium

Dr.

Quarterly Earnings Timeline

Financial verification status, call summary, sentiment, and management-delivery signals by quarter.

1 quarter

Q2 FY26 Date pending

Revenue ₹8,828 Cr (+10% YoY)

Dr.